NCT02247011

Brief Summary

This proposed study was designed to investigate the prevalence of a 5-year incident osteoporotic fracture and evaluate the association of a 5-year change of 25-hydroxyvitamin D (25\[OH\]D)/bone turnover makers/bone mineral density (BMD) with the incident fracture in the Chinese postmenopausal women, based on an endeavor of a 5-year post-baseline follow-up visit of a previous cross-sectional study, PK-VF, in which 1724 participants were enrolled and examined.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,100

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

September 19, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 23, 2014

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
5 months until next milestone

Results Posted

Study results publicly available

September 30, 2016

Completed
Last Updated

September 30, 2016

Status Verified

August 1, 2016

Enrollment Period

1.5 years

First QC Date

September 19, 2014

Results QC Date

May 19, 2016

Last Update Submit

August 8, 2016

Conditions

Keywords

bone mineral density25(OH)D

Outcome Measures

Primary Outcomes (7)

  • Non-vertebral Fracture Incidence

    Non-vertebral fractures were assessed by questionnaire survey.The overall incidence of non-vertebral fracture of the subjects is 7.18%( 70/975).

    5 year

  • Vertebral Fracture Incidence

    Vertebral fractures were assessed by lateral radiograph. The overall incidence of vertebral fracture of the subjects is 5.23%( 51/975)

    5 year

  • Bone Mineral Density

    bone mineral density of Lumbar spine and femoral neck were measured by dual-energy X-ray absorptiometry (DXA) (Lunar or Norland)

    5 year

  • Bone Turnover Markers and 25(OH)D

    C-terminal telopeptide of type I collagen (β-CTX), N-aminoterminal prepeptide of type I procollagen (P1NP), and 25-hydroxyvitamin D (25\[OH\]D) will be determined by a laboratory method of electrochemiluminescence (E170; Roche Diagnostics, Basel, Switzerland) in the institute (Peking Union)

    5 year

  • Biochemical Markers

    Fasting blood sample was collected for each subject. Common biochemical markers including serum calcium(Ca), serum phosphate(P), serum glucose(Glu), serum creatinine(Cr), alkaline phosphatase(ALP)were analyzed.

    5 year

  • Serum Alkaline Phosphatase

    Fasting blood sample was collected for each subject. The level of serum alkaline phosphatase (ALP) was analyzed.

    5 years

  • Serum Creatinine

    Fasting blood sample was collected for each subject.The level of serum creatinine(Cr) was analyzed.

    5 years

Study Arms (2)

fracture group

OTHER

Fracture group included participants with new fractures during the 5 year follow-up visit. Fracture consists of non-vertebral fracture and vertebral fracture, which were investigated by questionnaire survey and lateral radiographs, respectively.

Other: Questionaire surveyRadiation: Bone mineral density examinationRadiation: Vertebral fracture assessmentOther: Biochemical markers analysis

non-fracture group

OTHER

Fracture group included participants without new fractures during the 5 year follow-up visit. Fracture consists of vertebral fracture and non-vertebral fracture, which were investigated by questionnaire survey and lateral radiographs, respectively.

Other: Questionaire surveyRadiation: Bone mineral density examinationRadiation: Vertebral fracture assessmentOther: Biochemical markers analysis

Interventions

We used a questionnaireto collect clinical data of the subjects. The questionnaire includes basic data, menstruation and pregnancy, habits and customs, daily activity, common healthy situation, history of drugs and history of factures.

fracture groupnon-fracture group

We use dual energy X-ray absorptiometry (DXA) to exam the BMD at lumbar spine (L2-4, LS) and hip.

fracture groupnon-fracture group

X-ray of thoracic and lumbar spine was taken, and the pictures were read by radiological specialists. The diagnosis of vertebral fracture was executed according to Genant's semiquantitative technique.

fracture groupnon-fracture group

Fasting blood sample was collected for each subject. Common biochemical maerkers including serum calcium(Ca), serum phosphate(P), serum glucose(Glu), serum creatinine(Cr), alkaline phosphatase(ALP), alanine aminotransferase(ALT) were analyzed. Besides, we also detect bone speficific markers including 25-hydroxyl Vitamin D(25OHD), parathyroid hormone(PTH), β-isomerized C-terminal telopeptide of type I collagen(β-CTX), N-terminal procollagen of type 1 collagen(P1NP) and osteocalcin(OC).

fracture groupnon-fracture group

Eligibility Criteria

Age50 Years - 108 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • postmenopausal women (normally over 50 years old and years since menopause over than 1 year) in Peking.
  • participants without any fracture in 2007 PK-VF study were included in the prospective study investigating the association of bone turnover markers/BMD/25(OH)D with fracture incidence.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Endocrinology, Peking Union Medical College Hospital

Beijing, Beijing Municipality, 100730, China

Location

MeSH Terms

Conditions

Osteoporotic FracturesOsteoporosis, Postmenopausal

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesOsteoporosisBone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Results Point of Contact

Title
Dr. Weibo Xia
Organization
Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital,Chinese Academy of Medical Science

Study Officials

  • Weibo Xia, MD

    Department of Endocrinology, Peking Union Medical College Hospital

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 19, 2014

First Posted

September 23, 2014

Study Start

March 1, 2013

Primary Completion

September 1, 2014

Study Completion

May 1, 2016

Last Updated

September 30, 2016

Results First Posted

September 30, 2016

Record last verified: 2016-08

Locations